Molecular Partners AG Logo

Molecular Partners AG

ISIN: CH0256379097 | Ticker: MOLN | LEI: 875500AXMLDAZ4D21744
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Switzerland

About Molecular Partners AG

Company Description

We are pioneers: inventors and developers of an entirely new class of therapeutics.

As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases.

Our long-term strategy leverages our in-house DARPin design and development expertise combined with the capabilities of world-class partners to deliver a broad pipeline of innovative therapeutics.

Served area

Worldwide

Headcount

163

Headquarters

Wagistrasse 14, 8952 Schlieren – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
02.04.24 None Executive member Sell CHF 243,000.00
01.11.23 None Executive member Buy CHF 31,760.55
15.02.22 None Executive member Sell CHF 2,410,500.00
15.02.22 None Executive member Sell CHF 1,607,000.00

Capital markets information

ISIN

CH0256379097

LEI

875500AXMLDAZ4D21744

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.